These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 4272948)

  • 21. Human platelet fibrinogen: a protein different from plasma fibrinogen.
    Soria J; Soria C; Samama M; Poirot E; Kling C
    Pathol Biol (Paris); 1976 Dec; 24 Suppl():15-7. PubMed ID: 796805
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification of human platelet membrane fibrinogen receptors by immunochemical techniques.
    Kornecki E; Tuszynski GP; Niewiarowski S
    Haematologia (Budap); 1984; 17(3):387-98. PubMed ID: 6100105
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Snake venom proteinase inhibitors. I. Isolation and properties of two inhibitors of kallikrein, trypsin, plasmin, and alpha-chymotrypsin from the venom of Russell's viper (Vipera russelli).
    Takahashi H; Iwanaga S; Suzuki T
    J Biochem; 1974 Oct; 76(4):709-19. PubMed ID: 4279913
    [No Abstract]   [Full Text] [Related]  

  • 24. Studies on platelet plasma membranes. I. Characterization of surface proteins of human platelets labeled with diazotized (125i)-diiodosulfanilic acid.
    George JN; Potterf RD; Lewis PC; Sears DA
    J Lab Clin Med; 1976 Aug; 88(2):232-46. PubMed ID: 60457
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bovine platelet proteins. 3. Some properties of platelet fibrinogen.
    Solum NO; Lopaciuk S
    Thromb Diath Haemorrh; 1969 Jun; 21(3):428-40. PubMed ID: 5803075
    [No Abstract]   [Full Text] [Related]  

  • 26. Studies on platelet plasma membranes. II. Characterization of surface proteins of rabbit platelets in vitro and during circulation in vivo using diazotized (125i)-diiodosulfanilic acid as a label.
    George JN; Lewis PC; Sears DA
    J Lab Clin Med; 1976 Aug; 88(2):247-60. PubMed ID: 956684
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Aggregation of chymotrypsin-treated thrombasthenic platelets is mediated by fibrinogen binding to glycoproteins IIb and IIIa.
    Niewiarowski S; Kornecki E; Hershock D; Tuszynski GP; Bennett JS; Soria C; Soria J; Dunn F; Pidard D; Kieffer N
    J Lab Clin Med; 1985 Dec; 106(6):651-60. PubMed ID: 2999274
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sodium dodecyl sulfate-polyacrylamide gel electrophoresis studies on lobster fibrinogen and fibrin.
    Doolittle RF; Fuller GM
    Biochim Biophys Acta; 1972 May; 263(3):805-9. PubMed ID: 5034221
    [No Abstract]   [Full Text] [Related]  

  • 29. [Chronic peripheral arterial occlusive disease, platelet glycoproteins GPIIb-IIIa and GP Ib-IX, plasma von Willebrand factor and plasma fibrinogen concentrations in patients with type 2 diabetes mellitus].
    Gosk-Bierska I; Adamiec R; Doskocz W; Ciosek W
    Pol Arch Med Wewn; 2000; 103(3-4):139-45. PubMed ID: 11236240
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of active center and lysine binding sites of plasmin in plasmin-induced platelet activation and disaggregation.
    Lu H; Soria C; Li H; Soria J; Lijnen HR; Perrot JY; Caen JP
    Thromb Haemost; 1991 Jan; 65(1):67-72. PubMed ID: 1827215
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fate of fibrinopeptides in the reaction between human plasmin and fibrinogen.
    Lahiri B; Shainoff JR
    Biochim Biophys Acta; 1973 Mar; 303(1):161-70. PubMed ID: 4267201
    [No Abstract]   [Full Text] [Related]  

  • 32. Molecular composition and biological properties of soluble fibrin polymers encountered in thrombotic states.
    Bang NU; Hansen MS; Smith GF; Latallo ZS; Chang ML; Mattler LE
    Ser Haematol; 1973; 6(4):494-512. PubMed ID: 4277578
    [No Abstract]   [Full Text] [Related]  

  • 33. Plasma and platelet fibrinogen differ in gamma chain content.
    Francis CW; Nachman RL; Marder VJ
    Thromb Haemost; 1984 Feb; 51(1):84-8. PubMed ID: 6719392
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Invited letter concerning: aprotinin's effect in cardiopulmonary bypass.
    Edmunds LH
    J Thorac Cardiovasc Surg; 1993 Oct; 106(4):748-9. PubMed ID: 7692185
    [No Abstract]   [Full Text] [Related]  

  • 35. [Fibrinogen fractions and their complexes with fibrin monomers].
    Kowalski E
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1969; 92(1):20-7. PubMed ID: 4189367
    [No Abstract]   [Full Text] [Related]  

  • 36. Inhibitors of fibrinolysis: evidence of some instances of mutual potentiation.
    Coccheri S; De Rosa V
    J Clin Pathol; 1972 Jul; 25(7):627-8. PubMed ID: 4262716
    [No Abstract]   [Full Text] [Related]  

  • 37. Influence of ketone bodies on fibrinogen, thrombocytes, and fibrinolysin activity in rabbits.
    BRAHMANKAR DM; NATH MC
    Am J Physiol; 1963 Apr; 204():653-4. PubMed ID: 14014885
    [No Abstract]   [Full Text] [Related]  

  • 38. Activation of platelet fibrin-stabilizing factor by thrombin.
    Hung GW; Sonnichsen WJ; James HL; Ganguly P
    Biochim Biophys Acta; 1974 Dec; 371(2):511-8. PubMed ID: 4215455
    [No Abstract]   [Full Text] [Related]  

  • 39. Reduction of insolubilized fibrinogen.
    Matthias FR; Heene DL; Wegrzynowicz Z
    Thromb Res; 1974 Jun; 4(6):803-8. PubMed ID: 4844062
    [No Abstract]   [Full Text] [Related]  

  • 40. Unreliability in the estimation of the molecular weight of fibrinogen degradation products (FDPs) by polyacrylamide/sodium dodecyl sulphate electrophoresis (SDS/PAGE).
    Arocha-Piñango CL; Perales J; Carvajal Z
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1985; 112(5):737-41. PubMed ID: 2416650
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.